SB-245570 is a serotonin 5-HT1B receptor antagonist which was under development for the treatment of major depressive disorder but was never marketed. It was being developed by GlaxoSmithKline in the 1990s.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.